Therapy-related leukemia associated with high-dose 4-epi-doxorubicin and cyclophosphamide used as adjuvant chemotherapy for breast cancer.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 1994
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Adult (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Combined Modality Therapy (MeSH)
- Cyclophosphamide (MeSH)
- Epirubicin (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Leukemia, Myeloid, Acute (MeSH)
- Middle Aged (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal